- Home
- OBIO vs SNT Comparison
OBIO vs SNT Comparison
Compare OBIO & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- SNT
- Stock Information
- Founded
- OBIO 2017
- SNT 1965
- Country
- OBIO United States
- SNT Canada
- Employees
- OBIO N/A
- SNT N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- SNT Telecommunications Equipment
- Sector
- OBIO Health Care
- SNT Telecommunications
- Exchange
- OBIO Nasdaq
- SNT Nasdaq
- Market Cap
- OBIO 118.8M
- SNT 95.2M
- IPO Year
- OBIO N/A
- SNT 1993
- Fundamental
- Price
- OBIO $3.29
- SNT $4.44
- Analyst Decision
- OBIO Strong Buy
- SNT
- Analyst Count
- OBIO 5
- SNT 0
- Target Price
- OBIO $14.20
- SNT N/A
- AVG Volume (30 Days)
- OBIO 303.1K
- SNT 66.9K
- Earning Date
- OBIO 08-11-2025
- SNT 08-25-2025
- Dividend Yield
- OBIO N/A
- SNT N/A
- EPS Growth
- OBIO N/A
- SNT N/A
- EPS
- OBIO N/A
- SNT 0.18
- Revenue
- OBIO $2,886,000.00
- SNT $36,690,000.00
- Revenue This Year
- OBIO $20.47
- SNT N/A
- Revenue Next Year
- OBIO $11.45
- SNT N/A
- P/E Ratio
- OBIO N/A
- SNT $24.67
- Revenue Growth
- OBIO 30.23
- SNT 8.36
- 52 Week Low
- OBIO $2.37
- SNT $1.40
- 52 Week High
- OBIO $8.30
- SNT $5.04
- Technical
- Relative Strength Index (RSI)
- OBIO 60.31
- SNT 48.89
- Support Level
- OBIO $3.05
- SNT $4.27
- Resistance Level
- OBIO $3.24
- SNT $4.70
- Average True Range (ATR)
- OBIO 0.16
- SNT 0.26
- MACD
- OBIO 0.03
- SNT -0.06
- Stochastic Oscillator
- OBIO 93.75
- SNT 30.43
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.